首页> 外文期刊>Annals of laboratory medicine. >Comparison of the Accuracy of Noninvasive Hemoglobin Sensor (NBM-200) and Portable Hemoglobinometer (HemoCue) with an Automated Hematology Analyzer (LH500) in Blood Donor Screening
【24h】

Comparison of the Accuracy of Noninvasive Hemoglobin Sensor (NBM-200) and Portable Hemoglobinometer (HemoCue) with an Automated Hematology Analyzer (LH500) in Blood Donor Screening

机译:无创血红蛋白传感器(NBM-200)和便携式血红蛋白仪(HemoCue)与自动血液分析仪(LH500)在献血者筛查中的准确性比较

获取原文
       

摘要

Background: The Hb levels of prospective blood donors are usually determined using a finger prick test. A new noninvasive Hb device has the advantage of not causing any sampling pain. The purpose of this study was to evaluate the accuracy of the noninvasive Hb sensor and to compare its measurements with those of a currently used portable hemoglobinometer. Methods: Hb was measured using a noninvasive Hb sensor (NBM-200; OrSense, Israel), a portable hemoglobinometer (HemoCue; HemoCue AB, Sweden), and an automated hematology analyzer (LH500; Beckman Coulter, USA). The correlations between Hb measurements taken by the NBM-200 and HemoCue with those by an automated hematology analyzer were assessed using intraclass correlation coefficients (ICCs). Hb measurements were compared among 3 different Hb level groups. Results: The mean Hb values of 506 blood donors were 14.1 g/dL by the NBM-200, 14.0 g/dL by the LH500, and 14.3 g/dL by the HemoCue. The correlation between the LH500 and the NBM-200 was substantial (ICC=0.69), while that between the LH500 and the HemoCue agreed almost perfectly (ICC=0.86). Conclusions: The possibility to judge to be eligible for donors who are ineligible to donate was substantial when using NBM-200. Even though the NBM-200 has the apparent advantage of noninvasiveness, its use in pre-screening should be given meticulous attention. Since pre-donation testing is crucial to protecting donors’ health, complete evaluation of the instrument should be performed prior to use.
机译:背景:预期献血者的血红蛋白水平通常通过手指点刺试验来确定。一种新的非侵入性血红蛋白设备的优点是不会引起任何采样疼痛。这项研究的目的是评估无创血红蛋白传感器的准确性,并将其测量结果与当前使用的便携式血红蛋白仪进行比较。方法:使用无创Hb传感器(NBM-200;以色列OrSense),便携式血红蛋白仪(HemoCue; HemoCue AB,瑞典)和自动血液分析仪(LH500; Beckman Coulter,美国)测量Hb。使用组内相关系数(ICC)评估NBM-200和HemoCue进行的Hb测量与自动血液分析仪进行的Hb测量之间的相关性。在3个不同的Hb水平组之间比较了Hb测量。结果:506名献血者的平均Hb值在NBM-200中为14.1 g / dL,在LH500中为14.0 g / dL,在HemoCue中为14.3 g / dL。 LH500与NBM-200之间的相关性很强(ICC = 0.69),而LH500与HemoCue之间的相关性几乎完全一致(ICC = 0.86)。结论:使用NBM-200时,判断是否有资格不符合捐赠条件的捐赠者的资格的可能性很大。即使NBM-200具有无创性的明显优势,也应特别注意其在预筛查中的使用。由于捐赠前测试对于保护捐赠者的健康至关重要,因此在使用前应对仪器进行全面评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号